Byrne Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
5,078
-417
-8% -$81.8K 0.58% 45
2026
Q1
$1.08M Sell
5,495
-1,433
-21% -$278K 0.63% 49
2025
Q4
$1.2M Buy
6,928
+71
+1% +$12.9K 0.66% 42
2025
Q3
$1.31M Sell
6,857
-30
-0.4% -$5.32K 0.8% 35
2025
Q2
$1.24M Sell
6,887
-15
-0.2% -$2.6K 0.82% 33
2025
Q1
$1.17M Buy
6,902
+48
+0.7% +$7.88K 0.86% 35
2024
Q4
$1.03M Sell
6,854
-25
-0.4% -$3.89K 0.73% 47
2024
Q3
$1.07M Sell
6,879
-65
-0.9% -$9.71K 0.73% 46
2024
Q2
$954K Sell
6,944
-162
-2% -$22.2K 0.68% 46
2024
Q1
$946K Buy
7,106
+170
+2% +$22.1K 0.66% 51
2023
Q4
$954K Buy
+6,936
New +$912K 0.73% 47
2023
Q3
Sell
-6,827
Closed -$910K 50
2023
Q2
$960K Buy
6,827
+175
+3% +$24.1K 0.62% 48
2023
Q1
$941K Buy
6,652
+15
+0.2% +$2.15K 0.67% 48
2022
Q4
$1.04M Buy
6,637
+25
+0.4% +$3.59K 0.75% 41
2022
Q3
$811K Buy
6,612
+647
+11% +$85.2K 0.63% 58
2022
Q2
$793K Buy
5,965
+565
+10% +$77K 0.59% 57
2022
Q1
$739K Buy
5,400
+152
+3% +$21.2K 0.46% 69
2021
Q4
$908K Buy
+5,248
New +$799K 0.59% 50

Other funds holding DGX

Byrne Asset Management's DGX Position: Q2 2026 in Review

Byrne Asset Management reduced its Quest Diagnostics (DGX) stake by 7.6% in Q2 2026, selling an estimated $81.8K and leaving 5,078 shares worth $1.08M. The position accounts for 0.58% of the portfolio, ranked #45.

Byrne Asset Management first reported a position in DGX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.31M in Q3 2025. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Byrne Asset Management held 5,078 shares of Quest Diagnostics worth $1.08M as of Q2 2026.
  • Byrne Asset Management sold 417 Quest Diagnostics shares in Q2 2026, an estimated $81.8K.
  • Quest Diagnostics made up 0.58% of Byrne Asset Management's portfolio in Q2 2026, its #45 holding.
  • Byrne Asset Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 18 quarters since.
  • Byrne Asset Management's Quest Diagnostics position peaked at $1.31M in Q3 2025.
  • 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.